4//SEC Filing
Emergent BioSolutions Inc. 4
Accession 0001140361-17-011623
$EBSCIK 0001367644operating
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 4:18 PM ET
Size
12.9 KB
Accession
0001140361-17-011623
Insider Transaction Report
Form 4
Hauer Jerome M
Director
Transactions
- Other
Common Stock
2016-08-01+453→ 17,404 total - Other
Common Stock
2016-08-01+604→ 18,008 total - Sale
Common Stock
2017-03-08$31.27/sh−2,576$80,558→ 16,009 total - Other
Common Stock
2016-08-01+577→ 18,585 total - Other
Employee Stock Option (Right to buy)
2016-08-01+905→ 10,305 totalExercise: $25.47Exp: 2022-01-21→ Common Stock (10,305 underlying)
Footnotes (6)
- [F1]In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in January 2018.
- [F2]In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017 and May 2018.
- [F3]In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017, May 2018 and May 2019.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.25 to $31.32, inclusive.
- [F5]Consists of an option granted on January 22, 2015 under the company's stock incentive plan as amended and restated. In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant.
- [F6]The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001367644
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 4:18 PM ET
- Size
- 12.9 KB